Utah Medical Products Statistics
Total Valuation
UTMD has a market cap or net worth of $183.91 million. The enterprise value is $101.27 million.
Important Dates
The next estimated earnings date is Thursday, April 24, 2025, before market open.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Mar 14, 2025 |
Share Statistics
UTMD has 3.28 million shares outstanding. The number of shares has decreased by -3.68% in one year.
| Current Share Class | 3.28M |
| Shares Outstanding | 3.28M |
| Shares Change (YoY) | -3.68% |
| Shares Change (QoQ) | -2.58% |
| Owned by Insiders (%) | 7.12% |
| Owned by Institutions (%) | 64.96% |
| Float | 2.83M |
Valuation Ratios
The trailing PE ratio is 14.15.
| PE Ratio | 14.15 |
| Forward PE | n/a |
| PS Ratio | 4.80 |
| Forward PS | n/a |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.82 |
| P/FCF Ratio | 12.60 |
| P/OCF Ratio | 12.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.47, with an EV/FCF ratio of 6.94.
| EV / Earnings | 7.30 |
| EV / Sales | 2.48 |
| EV / EBITDA | 5.47 |
| EV / EBIT | 6.44 |
| EV / FCF | 6.94 |
Financial Position
The company has a current ratio of 25.64, with a Debt / Equity ratio of 0.00.
| Current Ratio | 25.64 |
| Quick Ratio | 23.18 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.29% and return on invested capital (ROIC) is 7.98%.
| Return on Equity (ROE) | 11.29% |
| Return on Assets (ROA) | 7.62% |
| Return on Invested Capital (ROIC) | 7.98% |
| Return on Capital Employed (ROCE) | 13.25% |
| Revenue Per Employee | $215,279 |
| Profits Per Employee | $73,021 |
| Employee Count | 190 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, UTMD has paid $2.93 million in taxes.
| Income Tax | 2.93M |
| Effective Tax Rate | 17.43% |
Stock Price Statistics
The stock price has decreased by -21.19% in the last 52 weeks. The beta is 0.06, so UTMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -21.19% |
| 50-Day Moving Average | 59.62 |
| 200-Day Moving Average | 64.40 |
| Relative Strength Index (RSI) | 24.90 |
| Average Volume (20 Days) | 17,823 |
Short Selling Information
The latest short interest is 71,661, so 2.18% of the outstanding shares have been sold short.
| Short Interest | 71,661 |
| Short Previous Month | 67,772 |
| Short % of Shares Out | 2.18% |
| Short % of Float | 2.54% |
| Short Ratio (days to cover) | 3.68 |
Income Statement
In the last 12 months, UTMD had revenue of $40.90 million and earned $13.87 million in profits. Earnings per share was $3.96.
| Revenue | 40.90M |
| Gross Profit | 24.14M |
| Operating Income | 15.73M |
| Pretax Income | 18.81M |
| Net Income | 13.87M |
| EBITDA | 18.53M |
| EBIT | 15.73M |
| Earnings Per Share (EPS) | $3.96 |
Full Income StatementBalance Sheet
The company has $82.98 million in cash and $338,000 in debt, giving a net cash position of $82.64 million or $25.18 per share.
| Cash & Cash Equivalents | 82.98M |
| Total Debt | 338,000 |
| Net Cash | 82.64M |
| Net Cash Per Share | $25.18 |
| Equity (Book Value) | 117.43M |
| Book Value Per Share | 35.21 |
| Working Capital | 92.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $14.83 million and capital expenditures -$230,000, giving a free cash flow of $14.60 million.
| Operating Cash Flow | 14.83M |
| Capital Expenditures | -230,000 |
| Free Cash Flow | 14.60M |
| FCF Per Share | $4.45 |
Full Cash Flow StatementMargins
Gross margin is 59.03%, with operating and profit margins of 38.46% and 33.92%.
| Gross Margin | 59.03% |
| Operating Margin | 38.46% |
| Pretax Margin | 41.08% |
| Profit Margin | 33.92% |
| EBITDA Margin | 45.30% |
| EBIT Margin | 38.46% |
| FCF Margin | 35.70% |